Skip to main content
Clinical Trials/NCT02600533
NCT02600533CompletedNot Applicable

Increasing Minority Group Participation in Clinical Trials a Randomized Controlled Study of an Office-based Educational Video

Vanderbilt University Medical Center2 sites in 1 country63 target enrollmentStarted: December 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
63
Locations
2
Primary Endpoint
study feasibility

Study Overview

Brief Summary

This study will measure the effects of an office-based, clinical trial education video on clinical trial knowledge and enrollment in clinical trials, in a clinical sample with no previous history of clinical trial participation. This study will also determine the feasibility of implementing an office-based video educational program.

Detailed Description

Clinical trials are essential to scientific discovery and are critical to translating research in to practice. Despite their significance, clinical trial participation rates remain low, especially among underrepresented minority groups. Several barriers exist to minority group participation in clinical trial, one of which lack of awareness about clinical trials. Video educational programs show promise as an effective strategy to increase knowledge and clinical trial participation. The specific aims are as follows:

  1. Measure the effects of an office-based, clinical trial education video on clinical trial knowledge and enrollment in clinical trials, in a clinical sample with no previous history of clinical trial participation.
  2. Determine the feasibility of implementing an office-based video educational program.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Participants will be patients of Vanderbilt-Ingram Cancer Center (VICC) with a diagnosis of cancer Participants will have no previous history of clinical trial research participation

Exclusion Criteria

  • Previous history of clinical trial research participation

Arms & Interventions

Standard care/control group

No Intervention

First, participants will complete a brief electronic survey measuring their opinions on clinical trials. Next, participants in the standard of care group will be provided standard educational resources (booklet and DVD), with no additional instructions. Participants in this groups will be informed that a team member will call him/her in approximately 1 week to ask him/her the (same) questions about clinical research.

Video viewing group

Experimental

First, participants will complete a brief electronic survey measuring their opinions on clinical trials. Next, participants in the video viewing group will watch the 10-minute DVD video on tablet devices using headphones in the clinic. Participants in this groups will be informed that a team member will call him/her in approximately 1 week to ask him/her the (same) questions about clinical research.

Intervention: Video viewing group (Procedure)

Outcomes

Primary Outcomes

study feasibility

Time Frame: 12 months

The stages of implementation completion (SIC) measure will be used as an internal tool utilized by the study team to track time to achievement of key implementation milestones. An 8-stage implementation plan to measure feasibility of the office-based educational program will be executed across 3 phases. Three scores will be derived from the SIC measure. The first score is the number of stages completed. The second score is the time spent at each stage. The third score is the proportion of activities completed at each stage. Implementation of the SIC model poses no additional burden on study participants.

Secondary Outcomes

  • Clinical trial participation(12 months)
  • Clinical trial knowledge survey(7-10 days)
  • Likelihood to participate survey(7-10 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Consuelo H Wilkins

Executive Director of the Meharry-Vanderbilt Alliance, Associate Professor

Vanderbilt University Medical Center

Study Sites (2)

Loading locations...

Similar Trials